title: Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression.
abstract: Oleanolic acid (OA) derivatives exhibit numerous pleiotropic effects in many cancers. The present study aimed to investigate the molecular mechanisms of 5'-amino-oleana-2,12-dieno[3,2-d]pyrimidin-28-oic acid (compound 4) and oleana-2,12-dieno[2,3-d]isoxazol-28-oic acid (compound 5) inducing apoptosis in human leukemia K562 cell. We investigated the effects of the compounds on K562 cell growth, apoptosis and cell cycle. The compounds showed strong inhibitory effects on K562 cell viability in a dose-dependent manner determined by the 3-(4,5-dimethylthiazoyl)-2,5-diphenyltetrazolium bromide assay and significantly increased chromatin condensation and apoptotic bodies in K562 cells. Flow cytometry assay suggested that the compounds induced inhibition of K562 cell proliferation associated with G1 phase arrest. In addition, the compounds inhibited Akt1 recruiting to membrane in CHO cells which express Akt1-EGFP constitutively and down-regulated the expression of pAkt1 in K562 cell. These results suggested that the compounds can efficiently inhibit proliferation and induce apoptosis perhaps involved in inactivation of Akt1. The OA derivatives may be potential chemotherapeutic agents for the treatment of human cancer.
authors.affiliation: College of Life Science, Zhejiang Sci-Tech University, Xiasha Higher Education Zone, Hangzhou, 310018, Zhejiang Province, China.
authors.forename: Shuhua
authors.initials: S
authors.lastname: Pan
authors.forename: Jun
authors.initials: J
authors.lastname: Hu
authors.forename: Tingting
authors.initials: T
authors.lastname: Zheng
authors.forename: Xinyuan
authors.initials: X
authors.lastname: Liu
authors.forename: Yong
authors.initials: Y
authors.lastname: Ju
authors.forename: Chuanlian
authors.initials: C
authors.lastname: Xu
references.citation: J Asian Nat Prod Res. 2009;11(2):122-7
references.pmid: 19219723
references.citation: Cancer Lett. 2001 Oct 30;172(2):119-26
references.pmid: 11566485
references.citation: Anticancer Res. 2011 Nov;31(11):3673-81
references.pmid: 22110186
references.citation: Chem Res Toxicol. 2011 Feb 18;24(2):238-45
references.pmid: 21158420
references.citation: J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
references.pmid: 17646672
references.citation: Biochem Biophys Res Commun. 2012 Jun 15;422(4):561-7
references.pmid: 22609405
references.citation: Cytotechnology. 2012 Aug;64(4):421-8
references.pmid: 22274625
references.citation: Pharmazie. 2013 Apr;68(4):293-9
references.pmid: 23700797
references.citation: Bioorg Med Chem Lett. 2008 Apr 15;18(8):2633-9
references.pmid: 18359628
references.citation: Oncol Lett. 2013 Jan;5(1):242-248
references.pmid: 23255929
references.citation: Int J Radiat Biol. 2006 Nov;82(11):761-70
references.pmid: 17148260
references.citation: Bioorg Med Chem Lett. 2007 Jun 1;17(11):2979-82
references.pmid: 17446070
references.citation: Cancer Res. 1994 Feb 1;54(3):701-8
references.pmid: 8306331
references.citation: J Agric Food Chem. 2010 May 26;58(10):6110-8
references.pmid: 20415421
references.citation: Pathol Oncol Res. 2013 Oct;19(4):763-70
references.pmid: 23661153
references.citation: Cancer Res. 2006 May 1;66(9):4758-65
references.pmid: 16651429
references.citation: J Biomol Screen. 2005 Feb;10(1):20-9
references.pmid: 15695340
references.citation: Mol Cancer Ther. 2007 May;6(5):1588-98
references.pmid: 17513608
references.citation: Curr Cancer Drug Targets. 2008 May;8(3):187-98
references.pmid: 18473732
references.citation: Regul Pept. 2012 Jun 10;176(1-3):13-21
references.pmid: 22387880
references.citation: Int J Oncol. 2013 Jun;42(6):1869-74
references.pmid: 23588713
references.citation: Acta Biochim Biophys Sin (Shanghai). 2007 Oct;39(10):803-9
references.pmid: 17928930
references.citation: Biochim Biophys Acta. 2008 Jan;1784(1):159-85
references.pmid: 17997386
references.citation: Eur J Pharmacol. 2012 Sep 15;691(1-3):61-8
references.pmid: 22824464
references.citation: Anticancer Res. 2007 Jul-Aug;27(4A):1777-82
references.pmid: 17649772
references.citation: J Biol Chem. 2001 Mar 30;276(13):9817-24
references.pmid: 11139588
references.citation: J Cell Physiol. 2012 Sep;227(9):3178-84
references.pmid: 22307544
references.citation: Science. 2005 Feb 18;307(5712):1098-101
references.pmid: 15718470
references.citation: Clin Transl Oncol. 2008 Oct;10(10):618-27
references.pmid: 18940742
references.citation: Recent Pat Anticancer Drug Discov. 2010 Jan;5(1):29-57
references.pmid: 19751211
references.citation: J Ginseng Res. 2013 Mar;37(1):74-9
references.pmid: 23717159
references.citation: In Vivo. 2005 Jul-Aug;19(4):683-8
references.pmid: 15999534
references.citation: Chem Biodivers. 2006 Jul;3(7):742-53
references.pmid: 17193306
references.citation: Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E187-96
references.pmid: 16014356